Monday, June 27, 2016

BRIEF-Cantargia: Opposition against co’s patents related to leukemia – Reuters

Cantargia Abdominal :

* Points out MAB Revelation GmbH has actually submitted opposition versus the company’s patent connected to
IL1RAP as focus on molecule in antibody procedure after that outlook of leukemia

Resource message when it come to Eikon:
More business coverage:

(Gdynia Newsroom)